The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
Conditions: COVID-19 Pneumonia; ARDS Intervention: Drug: Tocilizumab Sponsors: Sciberras, Stephen M.D.; Mater Dei Hospital, Malta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2021 Category: Research Source Type: clinical trials